Skip to main content
Over 3 Years, Atopic Dermatitis Well-Controlled with Lebrikizumab
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Over 3 Years, Atopic Dermatitis Well-Controlled with Lebrikizumab
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Atopic Dermatitis
0
0.89
Topical Corticosteroid
0
0.66
Biologic Therapy
0
0.56
Adverse Effects
0
0.47
Corticosteroids
0
0.47
Patient Safety
0
0.42
Washington DC
0
0.33
Europe
0
0.31
Monoclonal Antibody
0
0.31
Washington
0
0.31
Adolescent Medicine
0
0.16
Clinical Research
0
0.16
Conjunctivitis
0
0.16
Eczema
0
0.16
Germany
0
0.16
Interleukin
0
0.16
Severity Index
0
0.16
Cornea and External Disease
0
0.14
Healthcare and Medical Technology
0
0.14
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
1
Allergy & Clinical Immunology
0
0.99
Internal Medicine
0
0.92
Pediatrics
0
0.83
Pharmacist
0
0.78
Infectious Diseases
0
0.24
Ophthalmology
0
0.14
Edit Tags